Literature DB >> 9577951

Tumor necrosis factor-alpha confers resistance to hypoxic injury in the adult mammalian cardiac myocyte.

M Nakano1, A A Knowlton, Z Dibbs, D L Mann.   

Abstract

BACKGROUND: Previous studies in isolated cardiac myocytes have shown that tumor necrosis factor (TNF)-alpha provokes increased expression of 27- and 70-kD stress proteins as well as manganese superoxide dismutase, suggesting that TNF-alpha might play a role in mediating stress responses in the heart. METHODS AND
RESULTS: To determine whether TNF-alpha stimulation would protect isolated cardiac myocytes against environmental stress, myocyte cultures were pretreated with TNF-alpha for 12 hours and then subjected to continuous hypoxic injury (O2 content, 3 to 5 ppm) for 12 hours, followed by reoxygenation. Cell injury was assessed in terms of lactic dehydrogenase (LDH) release, 45Ca2+ uptake, and MTT metabolism. Pretreatment with TNF-alpha concentrations > or = 50 U/mL significantly attenuated LDH release by hypoxic cells compared with diluent-treated hypoxic cells. Similar findings were observed with respect to 45Ca2+ uptake and MTT metabolism in TNF-alpha-pretreated cells that were subjected to prolonged hypoxia. To determine the mechanism for the TNF-alpha-induced protective effect, the cells were pretreated with heat shock protein (HSP) 72 antisense oligonucleotides. These studies showed that the protective effect of TNF-alpha was not inhibited by antisense oligonucleotides, despite use of a concentration of antisense that was sufficient to attenuate the TNF-alpha-induced increase in HSP 72 expression. Subsequent studies using mutated TNF ligands showed that activation of both types 1 and 2 TNF receptors was sufficient to confer a protective response in isolated cardiac myocytes through an as yet unknown pathway(s).
CONCLUSIONS: Taken together, the above observations demonstrate that TNF-alpha pretreatment confers resistance to hypoxic stress in the adult cardiac myocyte through a novel mechanism that appears to be different from but not necessarily exclusive of the protective response conferred by HSP 72 expression.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9577951     DOI: 10.1161/01.cir.97.14.1392

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  33 in total

1.  Dichotomous actions of NF-kappaB signaling pathways in heart.

Authors:  Rimpy Dhingra; James A Shaw; Yaron Aviv; Lorrie A Kirshenbaum
Journal:  J Cardiovasc Transl Res       Date:  2010-05-25       Impact factor: 4.132

2.  β2 adrenergic activation induces the expression of IL-18 binding protein, a potent inhibitor of isoproterenol induced cardiomyocyte hypertrophy in vitro and myocardial hypertrophy in vivo.

Authors:  David R Murray; Srinivas Mummidi; Anthony J Valente; Tadashi Yoshida; Naveen K Somanna; Patrice Delafontaine; Charles A Dinarello; Bysani Chandrasekar
Journal:  J Mol Cell Cardiol       Date:  2011-10-08       Impact factor: 5.000

3.  Interleukin-18 knockout mice display maladaptive cardiac hypertrophy in response to pressure overload.

Authors:  James T Colston; William H Boylston; Marc D Feldman; Chris P Jenkinson; Sam D de la Rosa; Amanda Barton; Rodolfo J Trevino; Gregory L Freeman; Bysani Chandrasekar
Journal:  Biochem Biophys Res Commun       Date:  2007-01-16       Impact factor: 3.575

4.  Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy.

Authors:  Kai-Chun Yang; Xiucui Ma; Haiyan Liu; John Murphy; Philip M Barger; Douglas L Mann; Abhinav Diwan
Journal:  Circ Heart Fail       Date:  2014-10-22       Impact factor: 8.790

5.  Endogenous tumor necrosis factor protects the adult cardiac myocyte against ischemic-induced apoptosis in a murine model of acute myocardial infarction.

Authors:  K M Kurrelmeyer; L H Michael; G Baumgarten; G E Taffet; J J Peschon; N Sivasubramanian; M L Entman; D L Mann
Journal:  Proc Natl Acad Sci U S A       Date:  2000-05-09       Impact factor: 11.205

Review 6.  Recent insights into the role of tumor necrosis factor in the failing heart.

Authors:  D L Mann
Journal:  Heart Fail Rev       Date:  2001-03       Impact factor: 4.214

7.  Protease-activated receptor-2 modulates myocardial ischemia-reperfusion injury in the rat heart.

Authors:  C Napoli; C Cicala; J L Wallace; F de Nigris; V Santagada; G Caliendo; F Franconi; L J Ignarro; G Cirino
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

8.  Fingerprint of long non-coding RNA regulated by cyclic mechanical stretch in human aortic smooth muscle cells: implications for hypertension.

Authors:  Laura-Eve Mantella; Krishna K Singh; Paul Sandhu; Crystal Kantores; Azza Ramadan; Nadiya Khyzha; Adrian Quan; Mohammed Al-Omran; Jason E Fish; Robert P Jankov; Subodh Verma
Journal:  Mol Cell Biochem       Date:  2017-05-19       Impact factor: 3.396

9.  Primary aldosteronism can alter peripheral levels of transforming growth factor beta and tumor necrosis factor alpha.

Authors:  C A Carvajal; A A Herrada; C R Castillo; F J Contreras; C B Stehr; L M Mosso; A M Kalergis; C E Fardella
Journal:  J Endocrinol Invest       Date:  2009-10       Impact factor: 4.256

10.  The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart.

Authors:  Jana S Burchfield; Jian-Wen Dong; Yasushi Sakata; Feng Gao; Huei-Ping Tzeng; Veli K Topkara; Mark L Entman; Natarajan Sivasubramanian; Douglas L Mann
Journal:  Circ Heart Fail       Date:  2009-10-30       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.